Endometrial Histology and Safety on Non-Oral Routes of Hormone Therapy for Perimenopausal/Early Menopausal Women: Transdermal Estrogens and Vaginal Micronized Progesterone

THE PROBLEM OF OSTEOPOROSIS IN MENOPAUSAL WOMEN AND POSSIBLE SOLUTIONS

Global problems of modernity ◽

10.26787/nydha-2713-2048-2021-2-1-15-17 ◽

2021 ◽

Vol 2 (1) ◽

pp. 15-17

Author(s):

Maiorova M.O.

Keyword(s):

Hormone Therapy ◽

Bone Tissue ◽

Calcium Metabolism ◽

Management Strategy ◽

Menopausal Hormone Therapy ◽

Effective Management ◽

Treatment Of Osteoporosis ◽

Menopausal Women ◽

Prevention And Treatment

41 women with osteoporosis were examined. The age of the examined people ranged from 50 to 60 years. All the women were postmenopausal. As a result of the study, it was found that the most effective management strategy for such patients is a combination of menopausal hormone therapy and non-hormonal drugs that affect calcium metabolism in bone tissue, improve its metabolism and reduce resorption. If there are contraindications to MGT, prevention and treatment of osteoporosis should also be carried out using the appointment of non-hormonal drugs. In this case, the use of ipriflavone is effective.

Download Full-text

Effects of oral versus transdermal estradiol plus micronized progesterone on thyroid hormones, hepatic proteins, lipids, and quality of life in menopausal women with hypothyroidism

Menopause ◽

10.1097/gme.0000000000001811 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Juliana Kaminski ◽

Cleo Mesa Junior ◽

Helena Pavesi ◽

Beatriz Drobrzenski ◽

Gisah M. do Amaral

Keyword(s):

Quality Of Life ◽

Thyroid Hormones ◽

Menopausal Women ◽

Transdermal Estradiol ◽

Hepatic Proteins ◽

Micronized Progesterone

Download Full-text

Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women

Radiotherapy and Oncology ◽

10.1016/j.radonc.2007.10.003 ◽

2007 ◽

Vol 85 (3) ◽

pp. 336-345 ◽

Cited By ~ 10

Author(s):

Marc A. Bollet ◽

Youlia M. Kirova ◽

Guillemette Antoni ◽

Jean-Yues Pierga ◽

Brigitte Sigal-Zafrani ◽

...

Keyword(s):

Hormone Therapy ◽

Breast Cancers ◽

Concurrent Radiotherapy ◽

Large Breast ◽

Menopausal Women ◽

Post Menopausal

Download Full-text

Hormone therapy in menopausal women with fibroids: is it safe? (Literature review)

Medical alphabet ◽

10.33667/2078-5631-2019-2-14(389)-38-44 ◽

2019 ◽

Vol 2 (14) ◽

pp. 38-44

Author(s):

Ya. Z. Zaydieva

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Hormone Therapy ◽

Literature Search ◽

Effective Treatment Option ◽

Estrogen Receptor Modulators ◽

Increased Risk ◽

Menopausal Women ◽

Receptor Modulators ◽

Higher Doses

Hormone therapy is an effective treatment option for menopausal women, although prolonged use of hormone therapy is associated with a slightly increased risk of breast cancer, thromboembolism, and stroke. A literature search for studies evaluating the effects of hormone therapy in menopausal women with asymptomatic fibroids demonstrated variable effects of hormone therapy on the volume and size of the fibroids. Some studies have demonstrated an increase in size of pre-existing asymptomatic fibroids and formation of new fibroids with higher doses of progestogen in combination therapy. Selective estrogen receptor modulators having tissue-specific estrogen agonistic and antagonistic actions such as raloxifene have a favorable clinical profile and may be better alternatives in women with asymptomatic fibroids.

Download Full-text